ATAI logo

Combined Holdings of ATAI in All ARK ETFs

ATAI Life Sciences

ATAI is a biopharmaceutical company focused on developing psychedelic and non-psychedelic compounds for the treatment of mental health disorders. The company generates revenue by advancing these therapeutic compounds through clinical trials and potentially bringing them to market through strategic partnerships and collaborations.

Trades of ATAI in All Ark ETFs

The ten most recent trades of ATAI Life Sciences in all the Ark ETFs ETF.View all trades

Date
Direction
Market Value
% of Position
% of ETF
Apr 03, 2023Sell$220100.00%0.00%
Mar 31, 2023Sell$7707.66%0.00%
Mar 30, 2023Sell$8,30991.09%0.00%
Mar 29, 2023Sell$118,89592.31%0.01%
Mar 28, 2023Sell$1,725,33593.61%0.09%
Mar 23, 2023Sell$58,7553.43%0.00%
Mar 21, 2023Sell$17,2740.99%0.00%
Mar 10, 2023Sell$39,7352.00%0.00%
Mar 09, 2023Sell$10,6060.51%0.00%
Mar 08, 2023Sell$19,7820.91%0.00%